624 related articles for article (PubMed ID: 21722000)
1. Improved dissolution behavior of lipophilic drugs by solid dispersions: the production process as starting point for formulation considerations.
Srinarong P; de Waard H; Frijlink HW; Hinrichs WL
Expert Opin Drug Deliv; 2011 Sep; 8(9):1121-40. PubMed ID: 21722000
[TBL] [Abstract][Full Text] [Related]
2. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine.
Mahmah O; Tabbakh R; Kelly A; Paradkar A
J Pharm Pharmacol; 2014 Feb; 66(2):275-84. PubMed ID: 24433426
[TBL] [Abstract][Full Text] [Related]
4. Producing Amorphous Solid Dispersions via Co-Precipitation and Spray Drying: Impact to Physicochemical and Biopharmaceutical Properties.
Mann AKP; Schenck L; Koynov A; Rumondor ACF; Jin X; Marota M; Dalton C
J Pharm Sci; 2018 Jan; 107(1):183-191. PubMed ID: 28711592
[TBL] [Abstract][Full Text] [Related]
5. Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: formulation and process considerations.
Paudel A; Worku ZA; Meeus J; Guns S; Van den Mooter G
Int J Pharm; 2013 Aug; 453(1):253-84. PubMed ID: 22820134
[TBL] [Abstract][Full Text] [Related]
6. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion.
Potter C; Tian Y; Walker G; McCoy C; Hornsby P; Donnelly C; Jones DS; Andrews GP
Mol Pharm; 2015 May; 12(5):1377-90. PubMed ID: 25730138
[TBL] [Abstract][Full Text] [Related]
7. Melt extrusion with poorly soluble drugs.
Shah S; Maddineni S; Lu J; Repka MA
Int J Pharm; 2013 Aug; 453(1):233-52. PubMed ID: 23178213
[TBL] [Abstract][Full Text] [Related]
8. Expanding the Application and Formulation Space of Amorphous Solid Dispersions with KinetiSol®: a Review.
Ellenberger DJ; Miller DA; Williams RO
AAPS PharmSciTech; 2018 Jul; 19(5):1933-1956. PubMed ID: 29846889
[TBL] [Abstract][Full Text] [Related]
9. Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug.
Lakshman JP; Cao Y; Kowalski J; Serajuddin AT
Mol Pharm; 2008; 5(6):994-1002. PubMed ID: 19434852
[TBL] [Abstract][Full Text] [Related]
10. Fusion production of solid dispersions containing a heat-sensitive active ingredient by hot melt extrusion and Kinetisol dispersing.
Dinunzio JC; Brough C; Hughey JR; Miller DA; Williams RO; McGinity JW
Eur J Pharm Biopharm; 2010 Feb; 74(2):340-51. PubMed ID: 19818402
[TBL] [Abstract][Full Text] [Related]
11. Multiple Linear Regression Modeling To Predict the Stability of Polymer-Drug Solid Dispersions: Comparison of the Effects of Polymers and Manufacturing Methods on Solid Dispersion Stability.
Fridgeirsdottir GA; Harris RJ; Dryden IL; Fischer PM; Roberts CJ
Mol Pharm; 2018 May; 15(5):1826-1841. PubMed ID: 29533634
[TBL] [Abstract][Full Text] [Related]
12. Recent strategies in spray drying for the enhanced bioavailability of poorly water-soluble drugs.
Davis M; Walker G
J Control Release; 2018 Jan; 269():110-127. PubMed ID: 29117503
[TBL] [Abstract][Full Text] [Related]
13. Recent advances and patents in solid dispersion technology.
Iqbal B; Ali A; Ali J; Baboota S; Gupta S; Dang S; Shadab M; Sahni JK
Recent Pat Drug Deliv Formul; 2011 Sep; 5(3):244-64. PubMed ID: 21834778
[TBL] [Abstract][Full Text] [Related]
14. Conjugation of Hot-Melt Extrusion with High-Pressure Homogenization: a Novel Method of Continuously Preparing Nanocrystal Solid Dispersions.
Ye X; Patil H; Feng X; Tiwari RV; Lu J; Gryczke A; Kolter K; Langley N; Majumdar S; Neupane D; Mishra SR; Repka MA
AAPS PharmSciTech; 2016 Feb; 17(1):78-88. PubMed ID: 26283197
[TBL] [Abstract][Full Text] [Related]
15. Recent studies on the processes and formulation impacts in the development of solid dispersions by hot-melt extrusion.
Tran PHL; Lee BJ; Tran TTD
Eur J Pharm Biopharm; 2021 Jul; 164():13-19. PubMed ID: 33887388
[TBL] [Abstract][Full Text] [Related]
16. Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan.
Lee JY; Kang WS; Piao J; Yoon IS; Kim DD; Cho HJ
Drug Des Devel Ther; 2015; 9():2745-56. PubMed ID: 26045660
[TBL] [Abstract][Full Text] [Related]
17. Comparison of three different types of cilostazol-loaded solid dispersion: Physicochemical characterization and pharmacokinetics in rats.
Mustapha O; Kim KS; Shafique S; Kim DS; Jin SG; Seo YG; Youn YS; Oh KT; Yong CS; Kim JO; Choi HG
Colloids Surf B Biointerfaces; 2017 Jun; 154():89-95. PubMed ID: 28324691
[TBL] [Abstract][Full Text] [Related]
18. Hot melt extrusion versus spray drying: hot melt extrusion degrades albendazole.
Hengsawas Surasarang S; Keen JM; Huang S; Zhang F; McGinity JW; Williams RO
Drug Dev Ind Pharm; 2017 May; 43(5):797-811. PubMed ID: 27616147
[TBL] [Abstract][Full Text] [Related]
19. A combined mathematical model linking the formation of amorphous solid dispersions with hot-melt-extrusion process parameters.
Schittny A; Ogawa H; Huwyler J; Puchkov M
Eur J Pharm Biopharm; 2018 Nov; 132():127-145. PubMed ID: 30240820
[TBL] [Abstract][Full Text] [Related]
20. Impact of polymer type on bioperformance and physical stability of hot melt extruded formulations of a poorly water soluble drug.
Mitra A; Li L; Marsac P; Marks B; Liu Z; Brown C
Int J Pharm; 2016 May; 505(1-2):107-14. PubMed ID: 27012984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]